Cellcept (mycophenolate Mofetil recalls
The FDA has published 1 recall involving Cellcept (mycophenolate Mofetil since 2012. The latest was reported on 26 Dec 2012. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2012
Last 12 months0reported
Class I00% of total
Ongoing0latest 26 Dec 2012
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why cellcept (mycophenolate mofetil is recalled
Companies
By year
All cellcept (mycophenolate mofetil recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | CellCept (mycophenolate mofetil) capsules, 250 mg recalled by Genentech | Genentech | Packaging Defects | Nationwide |
Should you stop taking Cellcept (mycophenolate Mofetil?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.